BioSpace News Archive

According to QY Research Medical, the pediatric ultrasound market size was valued at $349.0 million in 2020 and is projected to reach $564.9 million by 2030, growing at a CAGR of 4.7% from 2020 to 2030.

Smart Meter, continues to lead the way in remote blood glucose monitoring for diabetes because of its ease of use and its superior cellular-enabled devices that deliver immediate, robust data.

Nerve Repair and Regeneration Market was valued at USD 9.56 billion in 2020 and is expected to reach USD 22.01 Billion by year 2028, at a CAGR of 10.9%.

Neuromodulation Market is forecast to reach USD 10.86 Billion by 2028, according to a new report by Reports and Data.

Trauma Products Market size was USD 5.01 Billion in 2020 and is expected to register a revenue CAGR of 8.1% during the forecast period.

AbbVie announced The Lancet published results from three pivotal Phase 3 clinical trials – ADVANCE, MOTIVATE and FORTIFY – evaluating risankizumab in patients with moderately to severely active Crohn’s disease who have had inadequate response, lost response or were intolerant to conventional or biologic therapy.

Dizal will present clinical results and updates from its four therapeutic candidates in solid tumors and hematologic malignancies at the 2022 Annual Meeting of the American Society of Cancer Oncology being held on June 3-7, 2022.

KDx Diagnostics and UroGPO announced today the partnership to provide the URO17® test (Research Use Only in the US) for the detection of bladder cancer.

Mr. Keith Anderson and Mr. Mark Lotz will be stepping down as directors of the Company effective May 31, 2022, to allow them more time to focus on their business.

Each Unit consists of one common share (a “Common Share”) and one Common Share purchase warrant (a “Warrant”).